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SUMMARY 
Glucocorticoid receptors in cytosol preparations from rat liver or mouse L cells are inactivated by 
phospholipase A2 or calf intestine alkaline phosphatase. Molybdate ion, an inhibitor of a variety of 
phosphatase enzymes, does not prevent inactivation of glucocorticoid binding capacity by alkaline 
phosphatase but it blocks inactivation by phospholipase A,. In neither case is the enzyme itself in- 
hibited, and the effect of molybdate on phospholipase-mediated inactivation appears to reflect the ability 
of molybdate to prevent receptor inactivation by the detergent action of lysophosphatides. 
INTRODUCTION 
The group 6A transition metal oxyanions, like vanadate 
and molybdate, have recently been shown to affect a var- 
iety of biological systems. At low concentrations (in the 
micromolar range and lower) they have been shown to 
inhibit (Na+ + K+)ATPases [l-3] and both acid [S] and 
alkaline phosphatases [S]. At high concentrations (in the 
range of I-1OmM) vanadate and molybdate have been 
reported to activate adenylate cyclase in plasma mem- 
branes [6,7], to inhibit protein degradation in intact hepa- 
tocytes [S], to cause an insulin-like stimulation of glucose 
oxidation in rat adipocytes [9], to stabilize steroid recep- 
tors in cytosol preparations [lo, 111, and to inhibit steroid 
receptor transformation to the DNA-binding state [12, 133. 
It has often been assumed that the effects of molybdate and 
vanadate at high concentrations may reflect inhibition of 
dephosphorylation or phosphate transfer reactions [6-lo]. 
We report here the unexpected observation that 1OmM 
molybdate does not prevent loss of glucocorticoid binding 
capacity caused by calf intestine alkaline phosphatase but 
it blocks inactivation of receptors by phospholipase A,. 
MATERIALS AND METHODS 
Livers were removed from 75-100 g male Sprague-Daw- 
ley rats that had been adrenalectomized by the dorsal 
route and maintained on 0.9% saline for 14 days prior to 
use. Livers were ruptured in 1.5 vol. of 10 mM Hepes buffer 
(pH 7.4) per g wet weight and cytosol (100,OOOg super- 
natant) was prepared as previously described [12]. L929 
mouse fibroblasts were grown in monolayer culture in Jok- 
lik medium with 10% bovine serum [lo]. Cells were har- 
vested in log phase growth, ruptured by Dounce homogen- 
ization in Hepes buffer and centrifuged for 1 h at 100,000 g. 
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* Triamcinolone acetonide is 9a-fluoro-11~,16a,l7a,21- 
tetrahydroxy-pregna-1,4-diene-3,20-dione 16,17-acetonide. 
Cytosol from rat liver was incubated at 20°C with 
150pg/ml of calf intestine alkaline phosphatase (Sigma 
Chemical Co., St. Louis, MO, 505 units per mg protein at 
25°C) and other additions as noted in the legend to Fig. 1. 
At various times, duplicate 0.4 ml aliquots were removed, 
incubated for 2 h at 0°C with 50 nM [‘Hltriamcinolone 
acetonide* (New England Nuclear, Boston, MA, 5.6 Ci/ 
mmol), and specific binding capacity was assayed as de- 
scribed previously [12]. Calf intestine alkaline phosphatase 
activity was assayed in 10mM Hepes buffer, pH 7.4, by a 
modification of the method of Cox and Griffin[14] using 
5 mM p-nitrophenyl phosphate as substrate. 
Cytosol from mouse L cells was incubated at 20°C with 
10 pg/ml of phospholipase A (from Vipera russelli, Sigma 
Chemical Co., 10 units per mg protein at pH 6.5 at 37°C) 
lOOpg/ml of asolectin, and 10mM sodium molybdate in 
the combinations noted in the legend to Fig. 2. All samples 
contained 0.4 mM CaCl,. At the indicated times, duplicate 
0.4 ml samples were removed and specific binding capacity 
was assayed as above. 
The effect of molybdate on phospholipase A activity 
(Part B of Fig. 2) was determined by incubating 0.1 mg/ml 
[N-methyl i4C]-phosphatidylcholine (New England 
Nuclear, 50 mCi/mmol) at 20°C with 10 pg/ml phospho- 
lipase A, 0.4mM CaCl, and L cell cytosol (60% of final 
incubation volume). After varying times of incubation, 
0.15 ml ahquots were removed and added to 0.015 ml 
1OOmM EGTA to stop the enzyme action. Samples, 
0.02 ml, were chromatographed on silicic acid-impregnated 
paper in chloroform-methanol-7 N ammonium hydroxide 
(200: 25 : 3, v/v). Phosphatidylcholine and lysophosphatidyl- 
choline were identified with iodine vapor and radioactivity 
was assayed. 
RESULTS AND DISCUSSION 
We have previously shown that calf intestine alkaline 
phosphatase inactivates glucocorticoid receptors in mouse 
L cell and rat liver cytosol to a state that does not bind 
steroid [15]. The unbound receptor is sensitive to inactiva- 
tion whereas the steroid-bound receptor is unaffected. 
Several observations support the conclusion that the 
enzyme effect is due to phosphatase action: it is dependent 
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Fig. 1. Inactivation of the ~~ucocoTticoid receptor by calf intestine alkaline phosphatase. A, cytosol was 
incubated at 2o’C with calf intestine alkaline phosphatase (O-----O). alkaline phosphatase and 10 mM 
sodium molybdate (t-----@). heat-inactivated alkaline phosphatase (n-----n), sodium molybdare 
(A-- -A), or 10 mM Hepes buffer alone (U- -0). At the indicated times, 0.4 ml aliquots were removed 
and specific glucocorticoid binding capacity was assayed as described under Methods. B, calf intestine 
alkaline phosphatase was incubated with 5 mM @trophenyl phasphate at 2o’C in the presence of 
10 mM molybdate (0) or bufTer alone (a) and at various times. aliquots were removed and assayed for 
p-nitrophenol. 
upon zinc; it is inhibited by arsenate, a competitive inhibi- 
tor of the enzyme; and both the dep~losphorylating and 
receptor-inactivating activities of the enzyme preparation 
copurify. As the transition metal ions have heen reported 
to inhibit both Escherichiu co/i alkaline phosphatase-cata- 
lyzed hydrolysis of ~-nitropheny~ phosphate [S] and pro- 
tein dephosphorylation by a variety of phnsphoprote~n 
phosphatases [16-I‘S]. we expected that molybdate would 
prevent receptor inactivation by calf intestine alkaline 
phosphatase. As shown in Fig. 1. even at a concentration of 
10 mM, molybdate does not prevent receptor inactivation 
(Panel A), and it does not inhibit d~phosphorylation of 
p-nitrophenyl phospate (Panel B) by this enzyme. 
Molybdate also has no effect on the ability of phospho- 
lipase A to convert phosphatidylcholine to lysophosphati- 
dy~chol~ne (Fig. 2B). but it completely inhibits the inactiva- 
tion of the L celt receptor by this enzyme at 2O’C (Fig. ZA). 
Phospholipase A has been shown to inactivate glucocorti- 
cold receptors in both mouse L cell [IS] and rat liver [ZOJ 
cytosol. The inactivation is due to the action of lysophos- 
phatides produced by hydrolysis of endogenous phospho- 
lipids [20]. As shown in Fig. 2A, addition of both phospho- 
lipase A and 100 vg/ml of its substrate asolectin results in 
greater inactivation than that observed with the enzyme 
alone and this inactivation is blocked by molybdate. Aso- 
lectin alone has no effect on the binding capacity (data not 
shown) but addition of a lysolecithin. such as L-cr-lysophos- 
phatidylcholine from egg yolk, and other types of deter- 
gents does inactivate the receptor 112, 19,201. We [ 121 and 
others[l3,21] have proposed that the transition metal 
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Fig. 2. Inactivation of the glucocorticoid receptor by phospholjpase AZ. A, cytosol from mouse L ceils 
was incubated at 20C with 10 ng/ml of phospholipase A (O-----O); phospholipase A and 1OmM 
sodium molybdate (O---O); phospholipase A and 100 tlg/rnI asolectin (&----A): phospholipase, aso- 
lectin and molybdate (A--A); or buffer (Cl). At the indicated times. 0.4 ml aliquots were removed and 
assayed for their ability to bind triamcinolone acetonide in a specific manner. 8, [‘4C]-phosphatidylcho- 
line was incubated at 20’C with phospho~pas~ A, CaCl 2, L cell cytosof and either i~~rnM sodium 
molybdate (closed symbols) or buffer (open symbols). After varying times of incubation, 0.15 ml aliquots 
were removed and radioactivity in phosphatidylcholine and lysophosphatidylcholine was assayed as 
described in the Methods. Results are expressed as a percent of the counts recovered as either phosphati- 
dyfcholine (m) or ~ysophosphatidyicholine (a). 
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oxyanions act through a weak association with the recep- 
tor itself and it appears that molybdate in this case is pre- 
venting inactivation due to detergent action of lysophos- 
phatides produced by the enzyme. 
Although the potent inhibition of several enzymes which 
hydrolyze phosphate ester bonds by low concentrations of 
vanadate and molybdate has been studied in some detail, 
we have no idea how these ions are acting to produce the 
variety of effects observed at higher concentrations. Van 
Etten et a/,[41 have proposed that the early transition 
metal oxyanions inhibit acid phosphatases at less than PM 
concentrations because they form complexes with a histidyl 
residue at the active site of the enzyme. Karlish et aI.[2] 
have suggested that vanadate inhibits (Na+ + K+) ATPase 
at low concentrations by blocking the conformational 
change that follows hydrolysis of the phosphoenzyme and 
Cantley et a[.[31 have proposed that vanadate binds to a 
phosphatase site on the ATPase. 
On the basis of the studies on ion effects at low concen- 
tration, various investigators have speculated that molyb- 
date and vanadate effects observed at high concentration, 
such as adenylate cyclase stimulation in plasma mem- 
branes [6,7] and inhibition of protein degradation [S] or 
stimulation of glucose oxidation [9] in intact cells, may 
reflect an action of these compounds on phosphate transfer 
or dephosphorylation reactions. In our original work [lo] 
and in that of Barnett et a/.[223 it was assumed that 
molybdate was inhibiting glucocorticoid receptor inactiva- 
tion and transformation by acting as a phosphatase inhibi- 
tor. It should be noted, however, that these compounds can 
bind to proteins and produce a variety of effects that are 
not related to inhibition of dephosphorylation or phos- 
phate transfer processes. In the case of steroid receptors, 
the early transition metal oxoanions can apparently inter- 
act in a weak and reversible manner with the receptor itself 
and inhibit receptor inactivation or transformation pro- 
duced by low concentrations of salt and precipitation with 
ammonium sulfate [ 12, 13,231. As shown here, the interac- 
tion of molybdate with the receptor does not affect inacti- 
vation by alkaline phosphatase but it blocks inactivation 
by lysophosphatides produced by the action of phospho- 
lipase A. Molybdate and vanadate can form complexes 
with imidazole and sulfhydryl moieties in proteins [24] and 
probably also with phosphate groups [ll]. The biological 
effects observed at high concentrations of molybdate and 
vanadate may reflect such weak interactions (e.g. between 
molybdate and receptor) and are not the same as the more 
specific effects on phosphatase enzymes observed at much 
lower concentration. 
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